Updates

In response to rising costs associated with growing regulatory demands related to clinical research, fees associated with reviews of industry sponsored clinical trials involving human subjects research will be increasing as of July 1, 2019.

Part 1: Overview

In ongoing efforts to improve efficiency and reduce burden, research submissions in WVU+kc will no longer require sign-off by a unit administrator (UA). Instead, UAs will receive notifications of study submissions via email that require no additional action.

WVU's Procurement Contracting and Payment Services department is offering a new prepaid card program effective (July 1) for all payments to participants in human subjects research. The new system, the Vincent Prepaid Card System is available now. For more information and assistance contact Procurement Contracting and Payment Services.

Starting July 1, 2020  WVU Health Sciences Center/Morgantown-based WVU Medicine clinical trials must be registered with the WVCTSI Clinical Trials Center of Excellence and obtain approval prior to starting patient enrollment.

COVID-19 Updates: Refer to the WVU Research Office COVID 19 Guidance for the most up-to-date information and guidance regarding research.

COVID-19 Update: If you will be collecting HIPAA-protected information from study subjects via video conferencing, contact HSC to obtain an account for WVU's HIPAA Compliant Zoom subscription. Basic (personal)  and WVU Main Campus Zoom subscriptions are not HIPAA compliant and should not be used for PHI, PII, or other data classified as Sensitive under WVU policy. 

WVU OHRP will no longer accept the following as Flex protocol submissions:

Federal Regulatory and institutional policy requires that PIs/Co-PIs have an Up-to-Date Conflict of Interest Disclosure on file with with WVU COI Office. 

Protocol submissions requiring Full Board review are now due 14 days prior to scheduled meetings, check the WVU OHRP website for specific due dates.